Cigarette smoke and adverse health effects: An overview of research trends and future needs

International Journal of Angiology

Volumn 16, Issue 3, 2007, Pages 77-83

  Saha, Sibu P ^a   Bhalla, Deepak K ^b   Whayne Jr , Thomas F ^a   Gairola, C G ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Atherosclerosis; Cancer; Smoking; Tobacco

Indexed keywords

EID: 80052981488     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0031-1278254     Document Type: Review

References (68)

1. World Health Organization. Tobacco or Health: A Global Status Report. Geneva: World Health Organization, 1997
2. The Health Consequences of Smoking: A Report of the Surgeon General. http://www.surgeongeneral.gov/library/smokingconsequences/(Version current at August 25, 2008).
3. Centers for Disease Control. Cigarette Smoking Among Adults-United States, 2004.
4. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5444a2.htm (Version current at August 25, 2008).
5. Murray J, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997;349:1498-504. (Pubitemid 27216360)
6. Doll R. Cancers weakly related to smoking. Br Med Bull 1996;52:35-49. (Pubitemid 26039047)
7. Doll R. Risk from tobacco and potentials for health gain. Int J Tuberc Lung Dis 1996;3:90-9.
8. Boyle P. Cancer, cigarette smoking and premature death in Europe: A review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996. Lung Cancer 1996;17:1-60. (Pubitemid 27261491)
9. Hoffman D, Hoffman I. The changing cigarette. J Toxicol Environ Health 1997;50:307-64.
10. Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 1997;105:875-82. (Pubitemid 27372975)
11. Powell J. Vascular damage from smoking: Disease mechanisms at the arterial wall. Vascular Med 1998;3:21-8. (Pubitemid 28267456)
12. Hutchinson S. Smoking as a risk factor for endothelial dysfunction. Can J Cardiol 1998;14:20D-2D.
13. Nitinberg A, Antony I, Foult JM. Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings. Am J Med 1993;95:71-7. (Pubitemid 23205929)
14. Celermajer D, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334:150-4. (Pubitemid 26017952)
15. Poredos P, Orehec M, Tratnik E. Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction. Angiology 1999;50:201-8. (Pubitemid 29138426)
16. Raitakari OT, Adams MR, McCredie RJ, Griffiths KA, Celermajer DS. Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med 1999;130:578-81. (Pubitemid 29169385)
17. Higman D, Strachan AM, Buttery L, et al. Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vasc Biol 1996;16:546-52. (Pubitemid 26107726)
18. Kiowski W, Linder L, Stoschitzky K, et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994;90:27-34. (Pubitemid 24203659)
19. Wang X, Sim AS, Badenhop R F, McCredie RM, Walckin DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996;2:41-5. (Pubitemid 26028071)
20. Rios DL, D'Onofrio LO, Souza JK, et al. Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian-and African-Brazilians. Atherosclerosis 2007;193:135-41. (Pubitemid 46795453)
21. Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM. Adverse effects of cigarette smoke on NO bioavailability: Role of arginine metabolism and oxidative stress. Hypertension 2006;48:278-85. (Pubitemid 44309824)
22. Lehr H. Adhesion-promoting effects of cigarette smoke on leukocytes and endothelial cells. Ann NY Acad Sci 1993;686:112-8.
23. Shen Y, Rattan V, Sultana C, Kalra VK. Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes. Am J Physiol 1996;270:H1624-33.
24. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996;93:1488-92. (Pubitemid 26115411)
25. Adams M, Jessup W, Celermajer DS. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: Reversibility with oral L-arginine but not vitamin C. J Am Coll Cardiol 1997;29:491-7. (Pubitemid 27116088)
26. Howard DJ, Ota RB, Briggs LA, Hampton M, Pritsos CA. Oxidative stress induced by environmental tobacco smoke in the workplace is mitigated by antioxidant supplementation. Cancer Epidemiol Biomarkers Prev 1998;7:981-8. (Pubitemid 28514097)
27. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Eng J Med 1995;332:1198-203.
28. Heitzer T, Yla HS, Wild E, Luoma J, Drexler H. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J Am Coll Cardiol 1999;33:499-505. (Pubitemid 29234213)
29. Steinberg F, Chait A. Antioxidant vitamin supplementation and lipid peroxidation in smokers. Am J Clin Nutr 1998;68:319-27. (Pubitemid 28355649)
30. US Department of Health and Human Services. Women and Smoking: A report of the surgeon general. http://www.surgeongeneral.gov/library/womenandtobacco/ index.html (Version current at August 25, 2008).
31. Patel JD. Lung cancer in women. J Clin Oncol 2005;23:3212-8. (Pubitemid 46211345)
32. International Early Lung Cancer Action Program Investigators, Henschke CI, Yip R, Miettinen OS. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA 2006;296:180-4. (Pubitemid 44050371)
33. Lash T, Aschengrau A. Active and passive cigarette smoking and the occurence of breast cancer. Am J Epidemiol 1999;149:5-12. (Pubitemid 29028856)
34. Pershagen G, Akerblom G, Axelson O, et al. Residential radon exposure and lung cancer in Sweden. N Eng J Med 1994;330:159-64. (Pubitemid 24026883)
35. Foy JW, Bombick BR, Bombick DW, Doolittle DJ, Mosberg AT, Swauger JE. A comparison of in vitro toxicities of cigarette smoke condensate from Eclipse cigarettes and four commercially available ultra low-"tar" cigarettes. Food Chem Toxicol 2004;42:237-43.
36. Lee PN. Lung cancer and type of cigarette smoked. Inhal Toxicol 2000;13:951-76.
37. Hoffman D, Revenson A, Hecht SS. The biological significance of tobacco-specific N-nitrosamines: Smoking and adenocarcinoma of the lung. Crit Rev Toxicol 1996;26:199-211. (Pubitemid 26111898)
38. Weston A, Godbold JH. Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: A meta-analysis. Environ Health Perspect 1997;105(Suppl 4):919-26. (Pubitemid 27372982)
39. Hengstler JG, Arand M, Herrero ME, Oesch F. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: Influence on cancer susceptibility. Recent Results Cancer Res 1998;154:47-85.
40. Zheng W, Deitz AC, Campbell DR, et al. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:233-9. (Pubitemid 29114201)
41. Slattery ML, Potter JD, Samowitz W, Bigler J, Caan B, Leppert M. NAT2, GSTM-1, cigarette smoking and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1998;7:1079-84. (Pubitemid 29001663)
42. Badawi AF, Stern SJ, Lang N P, Kadlubar F F. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility. Prog Clin Biol Res 1994;395:109-40.
43. Wu X, Amos CI, Kemp BL, et al. Cytochrome P450 2E1 Dral polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev 1998;7:13-8. (Pubitemid 28087136)
44. Hung HC, Chuang J, Chien YC, et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 1997;6:901-5. (Pubitemid 27481638)
45. Taioli E, Ford J, Trachman, J, Li Y, Demopoulos R, Garte S. Lung cancer risk and CYPIA1 genotype in African-Americans. Carcinogenesis 1998;19:813-7. (Pubitemid 28376772)
46. Dong SX, Ping ZZ, Xiao WZ, et al. Effect of active and passive cigarette smoking on CYP1A2-mediated phenacetin disposition in Chinese subjects. Ther Drug Monit 1998;20:371-5.
47. Soni M, Madurantakan M, Krishnaswamy K. Glutathione S-transferase Mu (GST Mu) deficiency and DNA adducts in lymphocytes of smokers. Toxicology 1998;126:155-62. (Pubitemid 28281138)
48. Nakachi K, Imai K, Hayashi S, Kawajuri K. Polymorphisms of CYP1A1 and gluthathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993;53:2994-9. (Pubitemid 23210302)
49. Okada T, Kawashima K, Fukushi S, Minakuchi T, Nishimura S. Association between a cytochrome P450 CYP1A1 genotype and incidence of lung cancer. Pharmacogenetics 1994;4:333-40.
50. Nebert D, McKinnon RA, Puga A. Human drug-metabolizing polymorphisms: Effects on risk of toxocology and cancer. DNA Cell Biol 1996;15:273-80. (Pubitemid 26124084)
51. Alexandrie AK, Sundberg MI, Seidegård J, Tornling G, Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: A study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 1994;15:1785-90.
52. Garcia-Closas M, Kelsey KT, Wiencke JK, Xu X, Wain JC, Christiani DC. A case control study of cytochrome P450 1A1, glutathione S transferase M1, cigarette smoking and lung cancer susceptibility. Cancer Causes Control 1997;8:544-53. (Pubitemid 27330485)
53. Vineis P, Bartsch H, Caporaso N, et al. Genetically based N-acetyltransferase metabolic polymorphism and low level environmental exposure to carcinogens. Nature 1994;369:154-6. (Pubitemid 24153439)
54. Brockmöller J, Cascorbi I, Kerb R, Roots I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 1996;56:3915-25. (Pubitemid 26284739)
55. Rebbeck T. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-43. (Pubitemid 27427630)
56. Hirvonen A, Nylund L, Kociba P, Husgafvel-Pursiainen DK, Vainio H. Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis 1994;15:813-5. (Pubitemid 24156874)
57. Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Canc Inst 1995;87:902-7.
58. Rojas M, Alexandrov K, Cascorbi I, et al. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes. Pharmacogenetics 1998;8:109-18. (Pubitemid 28227318)
59. Brockmöller J, Cascorbi I, Kerb R, Sachse C, Roots I. Polymorphisms in xenobiotic conjugation and disease predisposition. Toxicol Lett 1998;102-103:73-183.
60. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997;18:641-4. (Pubitemid 28132446)
61. Ryberg D, Skaug V, Hewer A, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997;18:1285-9. (Pubitemid 28134699)
62. Hainaut P, Hernandez T, Robinson A, et al. IARC database of p53 gene mutations in tumors an cell lines: Updated compilation, revised formats and new visualization tools. Nucleic Acids Res 1998;26:205-13. (Pubitemid 28291534)
63. Husgafvel-Pursiainen K, Ridanpaa M, Antilla S, Vainio H. P53 and ras gene mutations in lung cancer: Implications for smoking and occupational exposures. J Occup Environ Med 1995;37:69-76.
64. Husgafvel-Pursiainen K, Karjalainen A, Kannio A. Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations. Am J Respir Cell Mol Biol 1999;20:667-74. (Pubitemid 129495785)
65. Glantz S, Parmley WW. Passive smoking and heart disease: Mechanisms and risk. JAMA 1995;273:1047-53.
66. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1-1438.
67. Howard G, Wagenknecht LE, Diez-Roux A, et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998;279:119-24. (Pubitemid 28068301)
68. He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease-a meta-analysis of epidemiologic studies. N Engl J Med 1999;340:920-6. (Pubitemid 29141053)